Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness.
Maoyuan ZhaoTing WangZhouguang HuiPublished in: Thoracic cancer (2020)
This study revealed that stemness is a latent inhibitor of the resistance of lung cancer cisplatin-resistant cells and might be effectively inhibited by aspirin.